Three independent discounted-cash-flow-style models value Amphastar Pharmaceuticals, Inc. every trading day. 1 of 3 currently price AMPH above its market price.
| Free Cash Flow model | $-8.59 |
| Excess Profit model | $60.45 |
| Residual Earnings model | $15.81 |
| Dividend Discount model | — |
| Piotroski F-Score | 7 / 9 |
| Return on invested capital | +7.5% |
| Net debt / EBITDA | 4.9× |
| Gross margin | +49.5% |
| Revenue CAGR | +18.0% |
| Cash conversion | 1.6× |
| Dividend yield | — |
| Buyback yield | +3.2% |
These are StockKitty's default assumptions. In the app, the models recompute live as you adjust growth, discount rates, and margins — and the AI explains the bull case, bear case, and quality picture.
Open AMPH in StockKitty